On June 25, 2025, Takeda Pharmaceutical Co Ltd held its 149th Annual General Meeting where shareholders approved a year-end dividend of 98 JPY per share and elected ten new directors, with a total of bonuses of 460 million JPY allocated for two non-Audit Directors. The voting results showed strong approval with 98.73% for the dividend and varied approval rates for director elections, indicating solid shareholder support.